Publication Date | SPC No. | SPC Category | Details Rows may repeat to show multiple inventors or applicants depending on "Sort By" |
---|
26 April 2017
(Journal 6675)
| SPC/GB04/012 | Expired | Applicant: Janssen Pharmaceuticals, Inc. 1125 Trenton-Harbourton Road, Titusville, NJ 08560, United States of America
Product: Tramadol Hydrochloride, Paracetamol
Product Type: Medicinal Authorised: FR NL 25970 5 April 2002 UK PL 00242/0384 25 September 2003
Authorised Extension:
Patent No: EP0566709 Title: Composition comprising a Tramadol Compound and Acetaminophen, and its use
SPC No: SPC/GB04/012 Date Expired: 4 April 2017 |
26 April 2017
(Journal 6675)
| SPC/GB17/025 | Lodged | Applicant: Pharmacyclics LLC 995 East Arques Avenue, Sunnyvale, CA 94085 (US)
Product: Ibrutinib, or a pharmaceutically acceptable salt thereof
Product Type: Medicinal Authorised: UK EU/1/14/945 7 July 2015 UK C(2015)4704 7 July 2015
Authorised Extension:
Patent No: EP2529621 Title: Inhibitors of bruton's tyrosine kinase
SPC No: SPC/GB17/025 Date Lodged: 28 March 2017 |
26 April 2017
(Journal 6675)
| SPC/GB17/026 | Lodged | Applicant: Warner-Lambert Compnmay LLC 235, East 42nd Street, New York, New York 10017, USA
Product: Palbociclib, optionally in the form of a pharmaceutically acceptable salt, ester, amide or prodrug therof
Product Type: Medicinal Authorised: UK EU/1/16/1147 9 November 2016
Authorised Extension:
Patent No: EP1470124 Title: 2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3D]PYRIMIDIN-7-ONES
SPC No: SPC/GB17/026 Date Lodged: 29 March 2017 |
26 April 2017
(Journal 6675)
| SPC/GB17/027 | Lodged | Applicant: ImClone LLC 450 East 29th Street, 12th Floor, New York, NY, NY0016, United States of America
Product: Olaratumab (lartruvo®)
Product Type: Medicinal Authorised: UK EU/1/16/1143 11 November 2016
Authorised Extension:
Patent No: EP2100614 Title: Antibody against PDGFR-alpha for use in the treatment of tumours
SPC No: SPC/GB17/027 Date Lodged: 31 March 2017 |